A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment
Clinical trial NCT07518147 · RECRUITING
Trial details
- NCT number
- NCT07518147
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-15
- Primary completion
- 2029-12-01
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.